Instructions Magnesium sulfate 25 g
Composition
active ingredient: magnesium sulfate heptahydrate;
1 packet contains magnesium sulfate heptahydrate 10 g or 25 g;
1 container contains 25 g of magnesium sulfate heptahydrate.
Dosage form
Powder.
Main physicochemical properties: white crystalline powder or shiny colorless crystals.
Pharmacotherapeutic group
Osmotic laxatives. ATX code A06A D04.
Pharmacological properties
Pharmacodynamics.
Internal use causes a laxative effect. The drug also has choleretic and diuretic effects.
Pharmacokinetics.
The laxative effect is due to a change in osmotic pressure, delayed absorption of water from the intestines, dilution and increase in the volume of intestinal contents, and irritation of enteroreceptors, which helps facilitate the act of defecation.
Indication
Constipation. As an antidote for barium salt poisoning.
Contraindication
Increased individual sensitivity, acute inflammatory diseases of the gastrointestinal tract, intestinal obstruction, cholelithiasis, obstruction of the biliary tract, acute septic conditions, arterial hypotension, conditions associated with calcium deficiency and depression of the respiratory center, severe renal failure.
Special safety precautions
The drug is not recommended for systematic use.
Interaction with other medicinal products and other types of interactions
Reduces the effect of oral anticoagulants, cardiac glycosides, phenothiazines. Reduces the absorption of ciprofloxacin, tetracyclines, weakens the effect of streptomycin and tobramycin.
Pharmaceutically incompatible (precipitate is formed) with calcium preparations, ethanol (in high concentrations), carbonates, alkali metal phosphates, salts of arsenic acid, barium, strontium, clindamycin phosphate, hydrocortisone sodium succinate, polymyxin sulfate, procaine hydrochloride, salicylates and tartrates.
Application features
"Magnesium sulfate" is a traditional medicine for use according to indications, confirmed by long-term use.
The patient should consult a doctor if the symptoms of the disease do not disappear while using the medicine or if adverse reactions not listed in the instructions for medical use of the medicine are observed.
Use during pregnancy or breastfeeding
The drug is contraindicated during pregnancy.
During breastfeeding, use under medical supervision if the benefit to the mother outweighs the risk to the child.
Ability to influence reaction speed when driving vehicles or other mechanisms
No effect.
Method of administration and doses
As a laxative, magnesium sulfate is prescribed orally (at night or on an empty stomach 30 minutes before a meal) once a day: adults - 10-30 g in ½ cup of water, children over 12 years old - 10 g in ½ cup of water, children aged 6-12 years old are prescribed from 5 to 10 g (i.e. from half to the entire volume of the solution prepared at the rate of 10 g per ½ cup of water).
For chronic constipation, use in enemas: dissolve the contents of 1 packet (10 g) in 500 ml of water and use in the amount prescribed by the doctor.
In case of poisoning with soluble barium salts, adults should be given 20–25 g of powder dissolved in 200 ml of water orally.
Children.
Used in children over 6 years of age only as prescribed by a doctor.
Overdose
In case of overdose, diarrhea and vomiting may occur.
Treatment: intravenous administration of calcium chloride or calcium gluconate solution – 5–10 ml of a 10% solution, oxygen therapy, carbogen inhalation, artificial respiration, peritoneal dialysis or hemodialysis are performed. Therapy is symptomatic.
Adverse reactions
Abortion, exacerbation of inflammatory processes in the gastrointestinal tract, nausea, vomiting, allergic reactions. In case of prolonged use, water-salt metabolism disorders, nutritional disorders, and atony of the large intestine are possible.
Expiration date
5 years.
Storage conditions
Store in original packaging at a temperature not exceeding 25 ° C. Keep out of the reach of children.
Packaging
10 g or 25 g in bags, 25 g in containers.
Vacation category
Without a prescription.
Producer
PrJSC Pharmaceutical Factory "Viola".
Location of the manufacturer and its business address.
Ukraine, 69063, Zaporizhia region, Zaporizhia city, Akademika Amosova street, building 75.
Applicant: PrJSC Pharmaceutical Factory "Viola".
Location of the applicant.
Ukraine, 69063, Zaporizhia region, Zaporizhia city, Akademika Amosova street, building 75.
